查詢結果分析
相關文獻
- 影響缺血性中風病人到院後至靜脈注射血栓溶解劑時間之因素分析
- 急性腦梗塞中風的處理
- 小洞梗塞
- 病例介紹與用藥檢討(7)--阻塞性腦中風--陷窩性腦梗塞
- 復發性腦梗塞之危險因子與預後分析
- 偏頭痛合併年輕型腦中風與顱內動脈瘤--病例報告
- 貝爾氏麻痺合併年輕型腦中風--病例報告
- 低劑量靜脈tPA血栓溶解治療在中風病人的效果及安全性
- 糖尿病患長期血糖控制與初次腦梗塞嚴重度之相關性研究
- Gabapentin Therapy for Persistent Hiccups and Central Post-Stroke Pain in a Lateral Medullary Infarction--Two Case Reports and Literature Review
頁籤選單縮合
| 題 名 | 影響缺血性中風病人到院後至靜脈注射血栓溶解劑時間之因素分析=Factors Affecting the Door-to-Needle Time for Intravenous tPA in Acute Ischemic Stroke |
|---|---|
| 作 者 | 葉旭霖; 侯勝文; 王宗倫; 林素美; 葉建宏; 陳威宏; 楊翠華; 邱浩彰; 連立明; | 書刊名 | 臺灣醫學 |
| 卷 期 | 20:2 2016.03[民105.03] |
| 頁 次 | 頁117-123 |
| 分類號 | 415.922 |
| 關鍵詞 | 溶栓治療; 血栓溶解劑tPA; 中風; 腦梗塞; 入院至注射血栓溶解劑時間; Thrombolytic therapy; Tissue plasminogen activator; tPA; Stroke; Brain infarction; Door to needle time; DNT; |
| 語 文 | 中文(Chinese) |
| 中文摘要 | 使用tPA治療缺血性中風的效果會隨著到院至給藥時間(door to needle time, DNT)的延長而減低,本研究的目的在檢討有哪些原因會造成DNT大於60分鐘。分析2012及2013年的急性腦梗塞中風病人資料,將完成急性中風實驗室檢查及電腦斷層所需的時間定義為「完成所有檢驗所需時間」,分析「完成所有檢驗所需時間」與DNT>60分鐘是否相關,並分析DNT超過60分鐘的因素。結果:「完成所有檢驗所需時間」與DNT是否超過60分鐘沒有顯著相關;DNT超過60分鐘的因素,檢驗時間過長占23.8%,家屬因素占14.3%,病情因素占42.3%,行政因素占4.8%,無明顯原因占14.3%。結論:除了繼續努力縮短檢驗時間,我們應在等待檢驗結果的同時請家屬考慮適合時是否施打,儘早量體重、領藥、控制血壓,並考慮降低或取消臨床疾病嚴重度National Institutes of Health Stroke Scale 的下限。 |
| 英文摘要 | Efficacy of intravenous alteplase to treat acute ischemic stroke decreases with door-to-needle time (DNT). This study aimed to determine what led to DNT> 60 minutes. We analyzed the data of acute ischemic stroke patients in 2012 and 2013, and defined "door to all laboratory data" as the time needed to finish brain CT, CBC, and PT/aPTT. Then we tested whether "door to all laboratory data" time was associated with whether DNT was longer than 60 minutes. Lastly we analyzed the factors leading to DNT> 60 minutes. "Door to all laboratory data" time was not significantly related to whether DNT was longer than 60 minutes. Factors leading to DNT> 60 minutes, "laboratory time too long" corresponded to 23.8%, "family factor" 14.3%, "disease factor" 42.3%, "administration factor" 4.8%, and "no obvious cause" 14.3%. In order to further shorten the laboratory time, we should talk to family about whether to use alteplase if feasible, before the laboratory results are available. We should also measure the patients' weight, get alteplase at hand, and control the blood pressure as early as possible. Lastly, we should consider lowering or canceling the lower limit of National Institutes of Health Stroke Scale. |
本系統中英文摘要資訊取自各篇刊載內容。